Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression

Blood (2022) 139 (18): 2797–2815.

https://doi.org/10.1182/blood.2021013925

Published: 2022

Includes: Supplemental data

Journal Articles

The High Mobility Group A1 Chromatin Regulator Drives Immune Evasion during MPN Progression By Repressing Genes Involved in Antigen Presentation and Immune Attack

Joseph Kim, Jung-Hyun Kim, Leslie Cope, Liping Li, Raajit Rampal, Richard Koche, Donna M Williams, Jerry L. Spivak, Alison R. Moliterno, Linda Resar

Blood (2021) 138 (Supplement 1): 2546.

https://doi.org/10.1182/blood-2021-151139

Published: 2021

Journal Articles

HMGA1 Chromatin Regulators Drive Progression in Myeloproliferative Neoplasms through Epigenetic Rewiring to Induce Networks Involved in GATA2 and Proliferation

Liping Li, Jung-Hyun Kim, Wenyan Lu, Leslie Cope, Donna M Williams, Joseph Kim, Raajit Rampal, Richard Koche, Lingling Xian, Li Luo, Marija Vasiljevic, Daniel R Matson, Zhizhuang Joe Zhao, Ophelia Rogers, Matthew C. Stubbs, Karen Reddy, Jerry L. Spivak, Alison R. Moliterno, Linda Resar

Blood (2021) 138 (Supplement 1): 625.

https://doi.org/10.1182/blood-2021-144712

Published: 2021

Journal Articles

Essential Thrombocytosis: Redefinition in the Genomic Era

Donna M. Williams, PhD, Michael A McDevitt, MD PhD, Brady L Stein, MDMHS, Ophelia Rogers, Michael B. Streiff, MD, David Neal, Sophie Lanzkron, MD MHS, Linda M. S. Resar, MD, Christine O'Keefe, PhD, Jaroslaw P. Maciejewski, MD PhD, Jerry L. Spivak, MD, Alison R. Moliterno, MD

Blood (2014) 124 (21): 3205.

https://doi.org/10.1182/blood.V124.21.3205.3205

Published: 2014

Journal Articles

Single Cell Analysis Of JAK2 V617F Positive MPN Stem/Progenitor Cells In Chronic Phase and Leukemic Transformation

Jonathan M. Gerber, MD, Donna M. Williams, PhD, Ophelia Rogers, Sarah Morse, Hao Zhang, Michael A McDevitt, MD, PhD, Richard J. Jones, Jerry L. Spivak, MD, Alison R. Moliterno, MD

Blood (2013) 122 (21): 1609.

https://doi.org/10.1182/blood.V122.21.1609.1609

Published: 2013

Journal Articles

Polycythemia Vera: Redefinition in the Genomic Era

Alison R. Moliterno, MD, Donna M. Williams, PhD, Michael A McDevitt, MD, PhD, Brady L Stein, MD, Jonathan M. Gerber, MD, Ophelia Rogers, Michael B. Streiff, MD, Sophie Lanzkron, M.D., Linda Resar, M.D., Christine O'Keefe, PhD, Jaroslaw P. Maciejewski, MD, PhD, Jerry L. Spivak, MD

Blood (2012) 120 (21): 1754.

https://doi.org/10.1182/blood.V120.21.1754.1754

Published: 2012

Journal Articles

A Functional Thrombopoietin Receptor Is Required for Full Expression of Phenotype in a JAK2 V617F Transgenic Mouse Model of Polycythemia Vera

Jerry L. Spivak, MD, Akil Merchant, MD, Donna M. Williams, PhD, Ophelia Rogers, Wanming Zhao, Alison R. Moliterno, MD, Zhizhuang Joe Zhao, PhD

Blood (2012) 120 (21): 427.

https://doi.org/10.1182/blood.V120.21.427.427

Published: 2012

Journal Articles

A Molecular Basis for Risk Stratification in Polycythrmia Vera

Jerry L. Spivak, MD, Donna M. Williams, PhD, Ophelia Rogers, Michael Considine, M.S., Michael Ochs, Ph.D., Alison R. Moliterno, MD

Blood (2012) 120 (21): 429.

https://doi.org/10.1182/blood.V120.21.429.429

Published: 2012

Journal Articles

Buccal Mucosa Cells Are Unsuitable As a Control Tissue to Distinguish Somatic Hematopoietic Mutations From Germline Mutations: Nail DNA Is a Suitable Surrogate

Donna M. Williams, PhD, Ophelia Rogers, D. Treva Rowley, Josef T. Prchal, MD, Jerry L. Spivak, MD, Alison R. Moliterno, MD

Blood (2011) 118 (21): 5156.

https://doi.org/10.1182/blood.V118.21.5156.5156

Published: 2011

Journal Articles

The Leukemic Stem Cell in Polycythemia Vera and Primary Myelofibrosis Is Distinct From the Initiating JAK2 V617F-Positive Hematopoiertic Stem Cell

Jonathan M. Gerber, MD, Brownhilda Ngwang, Hao Zhang, Donna M. Williams, PhD, Ophelia Rogers, Richard J. Jones, Alison R. Moliterno, MD, Jerry L. Spivak, MD

Blood (2011) 118 (21): 613.

https://doi.org/10.1182/blood.V118.21.613.613

Published: 2011

Journal Articles

Disruption of the ASXL1 Gene Is Prevalent In PMF: Analysis of Molecular Genetics and Clinical Phenotypes

Brady L Stein, MD, Donna M Williams, PhD, Michael A McDevitt, MD, PhD, Christine L. O'Keefe, PhD, Ophelia Rogers, Jerry L Spivak, Jaroslaw Maciejewski, Alison R Moliterno, MD

Blood (2010) 116 (21): 3074.

https://doi.org/10.1182/blood.V116.21.3074.3074

Published: 2010

Journal Articles

Prognosis Is Genetically Fixed In Polycythemia Vera and Definable by Gene Expression Profiling

Jerry L Spivak, MD, Donna M Williams, PhD, Brady L Stein, MD, Alison Moliterno, Chunfa Jie, PhD

Blood (2010) 116 (21): 1987.

https://doi.org/10.1182/blood.V116.21.1987.1987

Published: 2010

Journal Articles

Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders

Zhaohui Ye, Huichun Zhan, Prashant Mali, Sarah Dowey, Donna M. Williams, Yoon-Young Jang, Chi V. Dang, Jerry L. Spivak, Alison R. Moliterno, Linzhao Cheng

Blood (2009) 114 (27): 5473–5480.

https://doi.org/10.1182/blood-2009-04-217406

Published: 2009

Includes: Supplemental data

Journal Articles

Thrombopoietin Receptor (MPL) Genotype Modifies the Myeloproliferative Phenotype in a JAK2 V617F Transgenic Mouse Model of Polycythemia Vera.

Jerry L. Spivak, MD, Donna M Williams, Brady L. Stein, MD, Ophelia Rogers, Tsivia Hochman, MS, Judith D. Goldberg, Sc.D., Wanming Zhao, Zhizhuang Joe Zhao, Alison R Moliterno, MD

Blood (2009) 114 (22): 964.

https://doi.org/10.1182/blood.V114.22.964.964

Published: 2009

Journal Articles

Clonal Dominance at the Progenitor Cell Level Defines Clinical Phenotype More Accurately Than the Neutrophil Allele Burden in JAK2 V617F -Positive MPD Patients.

Alison R. Moliterno, MD, Donna M. Williams, PhD, Ophelia Rogers, Mary Ann Isaacs, Jerry L. Spivak, MD

Blood (2007) 110 (11): 679.

https://doi.org/10.1182/blood.V110.11.679.679

Published: 2007

Journal Articles

Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression

Alison R. Moliterno, Donna M. Williams, Ophelia Rogers, Jerry L. Spivak

Blood (2006) 108 (12): 3913–3915.

https://doi.org/10.1182/blood-2006-03-008805

Published: 2006

Journal Articles

Mpl Genotype and Phenotype Correlations in the Chronic Myeloproliferative Disorders: Relationship of Mpl Mutations, JAK2V617F Status and Mpl Protein Expression.

Donna M. Williams, PhD, Ann H. Kim, BS, Ophelia Rogers, Jerry L. Spivak, MD, Alison R. Moliterno, MD

Blood (2006) 108 (11): 3615.

https://doi.org/10.1182/blood.V108.11.3615.3615

Published: 2006

Journal Articles

Disease Burden in the Chronic Myeloproliferative Disorders Correlates with the Stem Level of JAK2 V617F Expression.

Alison R. Moliterno, MD, Donna M. Williams, PhD, Ophelia Rogers, Mary Ann Isaacs, Jerry L. Spivak, MD

Blood (2006) 108 (11): 668.

https://doi.org/10.1182/blood.V108.11.668.668

Published: 2006

Journal Articles

Molecular Mimicry in the Chronic Myeloproliferative Disorders: Reciprocity between JAK2 V617F Genotype and Mpl Expression.

Alison R. Moliterno, MD, Donna M. Williams, PhD, Ophelia Rogers, Jerry L. Spivak, MD

Blood (2005) 106 (11): 3520.

https://doi.org/10.1182/blood.V106.11.3520.3520

Published: 2005

Journal Articles

Gender Counts: Defining the Core Genetic Profile of Polycythemia Vera.

Jerry L. Spivak, MD, Chunfa Jie, PhD, Donna M. Williams, PhD, Alison R. Moliterno, MD

Blood (2004) 104 (11): 660.

https://doi.org/10.1182/blood.V104.11.660.660

Published: 2004

NARROW

HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression

The High Mobility Group A1 Chromatin Regulator Drives Immune Evasion during MPN Progression By Repressing Genes Involved in Antigen Presentation and Immune Attack

HMGA1 Chromatin Regulators Drive Progression in Myeloproliferative Neoplasms through Epigenetic Rewiring to Induce Networks Involved in GATA2 and Proliferation

Essential Thrombocytosis: Redefinition in the Genomic Era

Single Cell Analysis Of JAK2 V617F Positive MPN Stem/Progenitor Cells In Chronic Phase and Leukemic Transformation

Polycythemia Vera: Redefinition in the Genomic Era

A Functional Thrombopoietin Receptor Is Required for Full Expression of Phenotype in a JAK2 V617F Transgenic Mouse Model of Polycythemia Vera

A Molecular Basis for Risk Stratification in Polycythrmia Vera

Buccal Mucosa Cells Are Unsuitable As a Control Tissue to Distinguish Somatic Hematopoietic Mutations From Germline Mutations: Nail DNA Is a Suitable Surrogate

The Leukemic Stem Cell in Polycythemia Vera and Primary Myelofibrosis Is Distinct From the Initiating JAK2 V617F-Positive Hematopoiertic Stem Cell

Disruption of the ASXL1 Gene Is Prevalent In PMF: Analysis of Molecular Genetics and Clinical Phenotypes

Prognosis Is Genetically Fixed In Polycythemia Vera and Definable by Gene Expression Profiling

Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders

Thrombopoietin Receptor (MPL) Genotype Modifies the Myeloproliferative Phenotype in a JAK2 V617F Transgenic Mouse Model of Polycythemia Vera.

Clonal Dominance at the Progenitor Cell Level Defines Clinical Phenotype More Accurately Than the Neutrophil Allele Burden in JAK2 V617F -Positive MPD Patients.

Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression

Mpl Genotype and Phenotype Correlations in the Chronic Myeloproliferative Disorders: Relationship of Mpl Mutations, JAK2V617F Status and Mpl Protein Expression.

Disease Burden in the Chronic Myeloproliferative Disorders Correlates with the Stem Level of JAK2 V617F Expression.

Molecular Mimicry in the Chronic Myeloproliferative Disorders: Reciprocity between JAK2 V617F Genotype and Mpl Expression.

Gender Counts: Defining the Core Genetic Profile of Polycythemia Vera.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only